Articoli con mandati relativi all'accesso pubblico - Peter LibbyUlteriori informazioni
Non disponibili pubblicamente: 29
Controlla
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo …
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
Mandati: US National Institutes of Health
Controlla
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
C Weber, A Zernecke, P Libby
Nature reviews immunology 8 (10), 802-815, 2008
Mandati: German Research Foundation
Controlla
Atherosclerosis and inflammation: overview and updates
GR Geovanini, P Libby
Clinical science 132 (12), 1243-1252, 2018
Mandati: US National Institutes of Health
Controlla
Inflammation in atherosclerosis—no longer a theory
P Libby
Clinical chemistry 67 (1), 131-142, 2021
Mandati: US National Institutes of Health, American Heart Association
Controlla
Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an …
PM Ridker, J MacFadyen, P Libby, RJ Glynn
The American journal of cardiology 106 (2), 204-209, 2010
Mandati: US National Institutes of Health
Controlla
Platelets regulate CD4+ T-cell differentiation via multiple chemokines in humans
N Gerdes, L Zhu, M Ersoy, A Hermansson, P Hjemdahl, H Hu, ...
Thrombosis and haemostasis 106 (08), 353-362, 2011
Mandati: Swedish Research Council
Controlla
Rationale and design of the CLEAR-outcomes trial: evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance
SJ Nicholls, AM Lincoff, HE Bays, L Cho, DE Grobbee, JJP Kastelein, ...
American heart journal 235, 104-112, 2021
Mandati: National Health and Medical Research Council, Australia, National Institute …
Controlla
Relationship of interleukin-1β blockade with incident gout and serum uric acid levels: exploratory analysis of a randomized controlled trial
DH Solomon, RJ Glynn, JG MacFadyen, P Libby, T Thuren, BM Everett, ...
Annals of internal medicine 169 (8), 535-542, 2018
Mandati: US National Institutes of Health
Controlla
Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy
PM Ridker, KR Tuttle, V Perkovic, P Libby, JG MacFadyen
European heart journal 43 (46), 4832-4844, 2022
Mandati: US National Institutes of Health
Controlla
Association of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with the risk of thromboembolism and mortality in patients with cancer
E Grilz, F Posch, O Königsbrügge, I Schwarzinger, IM Lang, C Marosi, ...
Thrombosis and haemostasis 118 (11), 1875-1884, 2018
Mandati: Austrian Science Fund
Controlla
New insights into plaque erosion as a mechanism of acute coronary syndromes
D Kolte, P Libby, IK Jang
Jama 325 (11), 1043-1044, 2021
Mandati: US National Institutes of Health, American Heart Association
Controlla
Lipoprotein (a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN
R Puri, CM Ballantyne, RC Hoogeveen, M Shao, P Barter, P Libby, ...
Atherosclerosis 263, 137-144, 2017
Mandati: German Research Foundation
Controlla
The clinical challenge of clonal hematopoiesis, a newly recognized cardiovascular risk factor
R Sidlow, AE Lin, D Gupta, KL Bolton, DP Steensma, RL Levine, BL Ebert, ...
JAMA cardiology 5 (8), 958-961, 2020
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, American …
Controlla
Chasing LDL cholesterol to the bottom—PCSK9 in perspective
P Libby, L Tokgözoğlu
Nature Cardiovascular Research 1 (6), 554-561, 2022
Mandati: US National Institutes of Health, American Heart Association, Leducq …
Controlla
Gamma-glutamyl transferase-to-platelet ratio as a novel predictor of long-term adverse outcomes in patients after undergoing percutaneous coronary intervention: a retrospective …
YY Zheng, TT Wu, Y Chen, XG Hou, Y Yang, X Ma, YT Ma, JY Zhang, ...
Thrombosis and haemostasis 119 (06), 1021-1030, 2019
Mandati: National Natural Science Foundation of China
Controlla
Culprit plaque morphology determines inflammatory risk and clinical outcomes in acute coronary syndrome
T Gerhardt, C Seppelt, YS Abdelwahed, D Meteva, C Wolfram, ...
European heart journal 44 (38), 3911-3925, 2023
Mandati: German Research Foundation
Controlla
Inhibiting NLRP3 inflammasome activity in acute myocardial infarction: a review of pharmacologic agents and clinical outcomes
LF Buckley, P Libby
Journal of Cardiovascular Pharmacology 74 (4), 297-305, 2019
Mandati: US National Institutes of Health, American Heart Association
Controlla
Inflammation and the pathogenesis of atherosclerosis
P Libby
Vascular Pharmacology 154, 107255, 2024
Mandati: US National Institutes of Health
Controlla
The role of eicosapentaenoic acid in reducing important cardiovascular events, including coronary revascularization
RD Bhatt, P Libby, S Verma, RP Mason, DL Bhatt
Progress in Cardiovascular Diseases 69, 3-10, 2021
Mandati: US National Institutes of Health
Controlla
PBMCs-derived microRNA signature as a prethrombotic status discriminator in stable coronary artery disease
J Gao, J Liu, Y Zhang, BY Guan, H Qu, H Chai, WT Wang, XJ Ma, DZ Shi
Thrombosis and Haemostasis 120 (01), 121-131, 2020
Mandati: National Natural Science Foundation of China
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software